Could cognitive impairment manifest in Behçet's disease even in the absence of neurological symptoms?
Year: 2024
Type: article
Study design: Observational Study
Abstract: Purpose: Behçet's disease (BD) is a chronic, multisystem inflammatory disorder that causes mortality and morbidity. Despite data indicating cognitive impairment in patients without neurological involvement, there is currently no consensus on how to screen patients. The Montreal Cognitive Assessment (MOCA) is a practical, easy-to-use screening scale that can detect mild cognitive impairment. We aimed to detect cognitive dysfunction with MOCA in BD without neurological findings. Materials and methods: This prospective study included patients diagnosed with BD without neurological findings, and healthy individuals matched for age, gender, and education. Behçet's Disease Current Activity Form (BDCAF) was applied to determine disease activity, and MOCA was applied to all participants. Results: The total score of the MOCA scale was significantly lower in Behçet's patients than in the control group (p0.05), scores in other subtests were significantly lower in patients (p
Source: Pamukkale Medical Journal
Institutions: Pamukkale University, Denizli Devlet Hastanesi
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4405215919